The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
Kate Knibbs is a senior writer at WIRED, where she explores the human side of the generative AI boom and examines how emerging technologies influence the arts, entertainment, and media industries. With a background that includes roles at The Ringer and Gizmodo, she delves into themes such as AI, culture, and business, often intersecting with topics like cryptocurrency and journalism. Kate's work has been featured in notable publications including WIRED Middle East, Ars Technica, and Mother Jones.












